CA-MATRIXX-SOFTWARE
MATRIXX Software today announces that Telstra , Australia’s leading telecommunications provider, has deployed MATRIXX and its Convergent Charging solution to deliver real-time mobile data usage alerts to millions of Telstra customers.
MATRIXX Convergent Charging enables service providers to deploy a single real-time platform for rating, balance management and charging across all access networks, services, devices and payment methods.
Telstra selected MATRIXX to enable the business to move to real-time data rating and notifications. By leveraging a convergent, real-time BSS platform across its mobile services portfolio Telstra has become the first operator in Australia to protect its consumer post-paid mobile customers with real-time mobile data usage alerts.
Scott McGibbony, Director of Mass Market Mobility at Telstra said the MATRIXX capabilities ensure Telstra can better protect customers from surprise data charges as Australians adopt high-speed 4G services.
“Bill shock can be a real frustration for our customers. Mobile data usage alerts dispatched by mobile operators in Australia are typically delayed by up to 48 hours, meaning mobile users can receive an alert after they have exceeded their allowance. We have worked with MATRIXX to take the worry out of using mobile data by offering our customers market-leading data usage SMS alerts that arrive in real time when they have used 50 percent, 85 percent and 100 percent of their monthly data allowance,” said Mr. McGibbony.
The MATRIXX solution has also enabled Telstra to improve the timeliness of data usage information available on its Telstra 24x7 app (iOS and Android) Telstra One app, My Plan Manager and My Account tools.
Mr McGibbony said the MATRIXX platform would help support future bill shock prevention initiatives and allow Telstra to introduce innovative new mobile plans.
Dave Labuda, Founder, CEO and CTO, MATRIXX Software, commented, “The platform has enabled Telstra to provide a step-change in user experience for subscribers in terms of ability to control their mobile data usage, avoid excess charges and data usage queries, and will provide other new capabilities for Telstra in the future.”
“Telstra chose MATRIXX Software because our real-time processing offers the level of performance, flexibility, and reliability required to protect customers at scale.”
To learn more about MATRIXX Software, please visit www.matrixx.com .
About MATRIXX Software
MATRIXX Software is Powering the FutureTM for market-leading Digital Service Providers (DSPs) worldwide.
Through patented real-time technology , MATRIXX enables service providers to innovate and profit from the transition to digital. The MATRIXX platform combines real-time charging, policy and analytics enablement to offer a differentiated customer experience.
Its technology provides DSPs with unique market advantages by delivering unrivalled performance. In deployment, it is proven to outperform existing real-time systems by greater than 100 times.
Using MATRIXX, DSPs can accelerate data monetization, rapidly deploy new service propositions and drive customer engagement.
Follow MATRIXX Software online:
Website: www.matrixx.com
YouTube: www.youtube.com/user/matrixxmarketing
Vimeo: www.vimeo.com/user17468378
LinkedIn: www.linkedin.com/company/586602
Twitter: www.twitter.com/matrixx_sw
Contact:
Babel PR for MATRIXX Software
+44 (0)20 7199 3974
matrixx@babelpr.com
or
MATRIXX
Software
Simon Marshall, +1 307-439-9000
Senior Manager,
Marketing and PR
simon.marshall@matrixx.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 14:00:00 CEST | Press release
Pivotal Study Advances to Establish Histotripsy as a Non-Thermal, Surgery-Free Alternative to Destroy and Liquefy Kidney Tumors HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison
Norwegian Tech Firm Builds Military Command Center in 24 Hours6.6.2025 13:45:00 CEST | Press release
Norwegian technology provider Cyviz has successfully developed a fully mobile and ballistic-proof command center - designed, configured, and made operational in just 24 hours. The solution was showcased during a military exercise led by the Dutch Ministry of Defence and has already sparked interest from NATO members and civil protection agencies across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606640770/en/ Cyviz demonstrates rapid deployment capability with a mobile, container-based control room for defense and crisis response Cyviz and its partners constructed the command room inside a 14-ton container designed for transport on standard military vehicles and resistant to machine gun fire. The unit was deployed at a military base in the Netherlands, where Cyviz was tasked with delivering a fully functional command-and-control environment, under strict time constraints and in a high-stakes simulation. "You do
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum